AOTI’s NEXA™ NPWT System Wins FDA Home Use Clearance

AOTI, Inc. (GB:AOTI) has released an update.

AOTI, Inc. has announced the U.S. FDA 510(k) clearance of its NEXA™ NPWT System for home care use, expanding its market reach beyond long-term care facilities. The NEXA™ NPWT System is a cost-effective, portable device for treating acute and chronic wounds, aiming to reduce hospital readmissions. This approval aligns with international market clearances and follows the company’s successful IPO, raising $17.5 million.

For further insights into GB:AOTI stock, check out TipRanks’ Stock Analysis page.